Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Taysha Gene Therapies, Inc.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-21Dec-31-20
   10-K10-K
Revenues  0.00.0
Cost of goods sold  0.00.0
Gross profit  0.00.0
Selling, general and administrative   [+]41.311.1
Research and development  131.931.9
EBITDA   [+]-172.8-43.0
Depreciation and amortization  0.50.0
EBIT   [+]-173.3-43.0
Interest expense  1.40.0
Other income (expense), net  0.2-17.0
Pre-tax income  -174.5-60.0
Income taxes  0.00.0
            Tax rate  0.0%0.0%
Net income  -174.5-60.0
   
Basic EPS   [+]($4.64)($3.40)
Diluted EPS   [+]($4.64)($3.40)
   
Shares outstanding (basic)   [+]37.717.7
Shares outstanding (diluted)   [+]37.717.7
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy